Insider Transactions in Q3 2024 at Viking Therapeutics, Inc. (VKTX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
216,130
-2.92%
|
$15,345,230
$71.19 P/Share
|
|
Sep 20
2024
|
Brian Lian President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
166,130
+6.18%
|
$1,162,910
$7.77 P/Share
|
|
Sep 20
2024
|
J Matthew Singleton |
SELL
Open market or private sale
|
Direct |
10,300
-52.02%
|
$710,700
$69.5 P/Share
|
|
Sep 20
2024
|
J Matthew Singleton |
BUY
Exercise of conversion of derivative security
|
Direct |
10,300
+34.22%
|
$10,300
$1.19 P/Share
|
|
Aug 21
2024
|
J Matthew Singleton |
SELL
Open market or private sale
|
Direct |
5,700
-37.5%
|
$393,300
$69.72 P/Share
|
|
Aug 21
2024
|
J Matthew Singleton |
BUY
Exercise of conversion of derivative security
|
Direct |
5,700
+27.27%
|
$5,700
$1.19 P/Share
|
|
Aug 21
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.04%
|
$69,000
$69.9 P/Share
|
|
Aug 21
2024
|
Brian Lian President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.04%
|
$7,000
$7.77 P/Share
|
|
Aug 19
2024
|
J Matthew Singleton |
SELL
Open market or private sale
|
Direct |
16,000
-15.07%
|
$992,000
$62.52 P/Share
|
|
Aug 19
2024
|
J Matthew Singleton |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+38.55%
|
$48,000
$3.33 P/Share
|
|
Aug 19
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
112,870
-1.54%
|
$7,449,420
$66.27 P/Share
|
|
Aug 19
2024
|
Brian Lian President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
112,870
+4.37%
|
$790,090
$7.77 P/Share
|
|
Aug 14
2024
|
J Matthew Singleton |
SELL
Open market or private sale
|
Direct |
20,786
-34.88%
|
$1,184,802
$57.95 P/Share
|
|
Aug 14
2024
|
J Matthew Singleton |
BUY
Exercise of conversion of derivative security
|
Direct |
20,786
+40.7%
|
$166,288
$8.0 P/Share
|
|
Jul 30
2024
|
Brian Lian President & CEO |
SELL
Open market or private sale
|
Direct |
115,859
-1.58%
|
$6,603,963
$57.85 P/Share
|
|
Jul 30
2024
|
Marianna Mancini Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
18,026
-2.39%
|
$1,027,482
$57.4 P/Share
|
|
Jul 30
2024
|
Greg Zante Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,136
-2.69%
|
$919,752
$57.79 P/Share
|
|
Jul 29
2024
|
Brian Lian President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
204,333
+3.97%
|
-
|
|
Jul 29
2024
|
Marianna Mancini Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,667
+4.05%
|
-
|
|
Jul 29
2024
|
Greg Zante Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,334
+6.59%
|
-
|